<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedBookArticle>    <BookDocument>        <PMID Version="1">30226696</PMID>        <ArticleIdList>            <ArticleId IdType="bookaccession">NBK525683</ArticleId>        </ArticleIdList>        <Book>            <Publisher>                <PublisherName>Canadian Agency for Drugs and Technologies in Health</PublisherName>                <PublisherLocation>Ottawa (ON)</PublisherLocation>            </Publisher>            <BookTitle book="rc0911">Concurrent Treatment for Substance Use Disorder and Trauma-Related Comorbidities: A Review of Clinical Effectiveness and Guidelines</BookTitle>            <PubDate>                <Year>2017</Year>                <Month>08</Month>                <Day>16</Day>            </PubDate>            <AuthorList Type="authors">                <Author>                    <LastName>Banerjee</LastName>                    <ForeName>Srabani</ForeName>                    <Initials>S</Initials>                </Author>                <Author>                    <LastName>Spry</LastName>                    <ForeName>Carolyn</ForeName>                    <Initials>C</Initials>                </Author>            </AuthorList>            <CollectionTitle book="cadthrdcollect">CADTH Rapid Response Reports</CollectionTitle>            <Medium>Internet</Medium>        </Book>        <Language>eng</Language>        <PublicationType UI="D016454">Review</PublicationType>        <Abstract>            <AbstractText>The purpose of this report is to review treatment options for patients with comorbid substance use disorder (SUD) and post-traumatic stress disorder, anxiety, or depression by comparing (1) concurrent treatments for SUD and the mental disorders with no treatment, usual care or active treatment for one condition only and (2) treatment for a single condition (SUD or the mental disorders) with no treatment, usual care or active treatment for the second disorder. Additionally, this review aims to review evidence-based guidelines regarding the treatments for patients with these comorbidities.</AbstractText>            <CopyrightInformation>Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.</CopyrightInformation>        </Abstract>    </BookDocument>    <PubmedBookData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30226696</ArticleId>        </ArticleIdList>    </PubmedBookData></PubmedBookArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30227315</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1573-2517</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>243</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>May</Month>                        <Day>31</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of affective disorders</Title>                <ISOAbbreviation>J Affect Disord</ISOAbbreviation>            </Journal>            <ArticleTitle>Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.</ArticleTitle>            <Pagination>                <MedlinePgn>55-61</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0165-0327(17)32495-3</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2018.05.040</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Bipolar disorder (BD) II is more likely to be misdiagnosed as major depressive disorder (MDD) than other types of BD, leading to incorrect treatment and poor outcomes. Previous studies have shown inconsistent results regarding the differences in cognitive deficits between the two disorders. To eliminate the compounding effects of medication and aging, we sought to investigate changes in cognitive function in medication-naïve, non-late-life patients with BDII and MDD.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Three subject groups were enrolled: 30 depressed BDII patients, 30 depressed MDD patients and 30 healthy controls. All subjects underwent a battery of cognitive tests to assess 8 cognitive domains. The cognitive domains were compared between the three subject groups. In BDII and MDD, the effect sizes were computed as evaluation parameters, weighing the degree of the cognitive deficits and the correlations between cognitive test deficits and clinical variables were also computed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the controls, the BDII and MDD patients were characterized by similar deficits in psychomotor speed, working memory, visual memory, attention switching and verbal fluency. Moderate to severe deficits in the majority of cognitive tests were observed in the BDII and MDD patients. Furthermore, correlations between the modified Wisconsin Card Sorting Test total errors and age of onset in the BDII patients and between correct digit span responses (backward and total) and depressive severity were found in the MDD patients.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest that BDII and MDD patients may suffer from similar profiles of cognitive domain deficits that may not assist in distinguishing between the two disorders. In addition, cognitive deficits may be correlated with the age of onset and depressive severity in mood disorders.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Tao</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Guangzhou Huiai Hospital, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhong</LastName>                    <ForeName>Shuming</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, The First Affiliated Hospital of Jinan University, Guangzhou, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Bing</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Affective Disorder, Shenzhen Mental Health Center, Shenzhen, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liao</LastName>                    <ForeName>Xiaoxiao</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology, Jiangmen Central Hospital, Jiangmen, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lai</LastName>                    <ForeName>Shunkai</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, The First Affiliated Hospital of Jinan University, Guangzhou, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jia</LastName>                    <ForeName>Yanbin</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, The First Affiliated Hospital of Jinan University, Guangzhou, China. Electronic address: yanbinjia2006@163.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>05</Month>                <Day>31</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>J Affect Disord</MedlineTA>            <NlmUniqueID>7906073</NlmUniqueID>            <ISSNLinking>0165-0327</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Bipolar disorder</Keyword>            <Keyword MajorTopicYN="N">Cognitive domain</Keyword>            <Keyword MajorTopicYN="N">Major depressive disorder</Keyword>            <Keyword MajorTopicYN="N">Medication-naïve</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>12</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>03</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30227315</ArticleId>            <ArticleId IdType="pii">S0165-0327(17)32495-3</ArticleId>            <ArticleId IdType="doi">10.1016/j.jad.2018.05.040</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30226630</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1652-7518</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>115</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Lakartidningen</Title>                <ISOAbbreviation>Lakartidningen</ISOAbbreviation>            </Journal>            <ArticleTitle>[A Swedish example of integrated perinatal mental health care].</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">E9ES</ELocationID>            <Abstract>                <AbstractText>Mental disorders are common during the perinatal period and expose mother and child to major risks.  Almost all women in Sweden attend maternal and child health care centers regularly before and after birth. This constitutes a unique opportunity to detect women with early signs of mental disorder or at risk of recurrence of prior illness. Identified women need fast access to diagnostic and treatment providers with specialized knowledge on perinatal mental disorders. As perinatal mental disorders can have severe consequences for mothers and their children a tight cooperation between caregivers is often needed.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Blomdahl Wetterholm</LastName>                    <ForeName>Margareta</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Stockholms läns sjukvårdsområde - Konsultenheten Psykiatri Sydväst Huddinge, Sweden Stockholms läns sjukvårdsområde - Konsultenheten Psykiatri Sydväst Huddinge, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bendix</LastName>                    <ForeName>Marie</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>SLSO - Psykiatri Sydväst Konsultenheten Stockholm, Sweden SLSO - Psykiatri Sydväst Konsultenheten Stockholm, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pettersson</LastName>                    <ForeName>Karin</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Patientområde graviditet och förlossning, Karolinska Universitetssjukhuset K57 - Stockholm, SE 14186, Sweden Patientområde graviditet och förlossning, Karolinska Universitetssjukhuset K57 - Stockholm, SE 14186, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lindefors</LastName>                    <ForeName>Nils</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Karolinska Institutet - Klinisk Neurovetenskap, Centrum för psykiatriforskning Stockholm, Huddinge, Sweden Karolinska Institutet - Clinical Neuroscience Stockholm, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>swe</Language>            <PublicationTypeList>                <PublicationType UI="D004740">English Abstract</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <VernacularTitle>Bättre perinatalpsykiatrisk vård genom integrerat samarbete - Obstetrik och psykiatri i samverkan kan leda till minskade risker för mor och barn.</VernacularTitle>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Sweden</Country>            <MedlineTA>Lakartidningen</MedlineTA>            <NlmUniqueID>0027707</NlmUniqueID>            <ISSNLinking>0023-7205</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30226630</ArticleId>            <ArticleId IdType="pii">E9ES</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30226104</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1440-1665</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists</Title>                <ISOAbbreviation>Australas Psychiatry</ISOAbbreviation>            </Journal>            <ArticleTitle>Obtaining consent for non-psychiatric treatment of persons detained under mental health legislation in Australia and New Zealand: is there cross-jurisdictional consistency?</ArticleTitle>            <Pagination>                <MedlinePgn>1039856218797444</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1039856218797444</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">It is increasingly recognised that persons with mental illness experience physical health issues at greater rates than the general population and that there are significant barriers to accessing appropriate treatment. One less obvious barrier to appropriate care may be the law. This review examines the legal regimes within Australia and New Zealand that regulate consent for medical and surgical treatment for persons detained under mental health legislation. The review begins with a brief overview of concepts of consent and capacity then examines the law with regards to consent for non-psychiatric treatment for persons detained in psychiatric facilities. The complexity and cross-jurisdictional consistency is considered and potential future directions and possibilities for reform are discussed.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Examination of the different laws regarding consent for medical or surgical treatment for persons admitted to psychiatric facilities are complex and demonstrate lack of consistency across jurisdictions. Reform in this area might be considered to achieve greater consistency and clarity for both health professionals and consumers.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Daws</LastName>                    <ForeName>Tessa</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Psychiatry Registrar, Sydney Local Health District, Camperdown, NSW, Australia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Australas Psychiatry</MedlineTA>            <NlmUniqueID>9613603</NlmUniqueID>            <ISSNLinking>1039-8562</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">capacity</Keyword>            <Keyword MajorTopicYN="N">consent</Keyword>            <Keyword MajorTopicYN="N">substitute decision-making</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30226104</ArticleId>            <ArticleId IdType="doi">10.1177/1039856218797444</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30224269</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1545-7214</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>07</Day>                    </PubDate>                </JournalIssue>                <Title>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</Title>                <ISOAbbreviation>Am J Geriatr Psychiatry</ISOAbbreviation>            </Journal>            <ArticleTitle>Community-Based Outreach and Treatment for Underserved Older Adults With Clinically Significant Worry: A Randomized Controlled Trial.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S1064-7481(18)30443-3</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jagp.2018.07.011</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether Calmer Life (CL) improved worry, generalized anxiety disorder-related (GAD-related) symptoms, anxiety, depression, sleep, trauma-related symptoms, functional status, and quality of life better than Enhanced Community Care with Resource Counseling (ECC-RC) at 6 months and 9 months.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">A randomized, controlled, comparative-effectiveness study involving underserved, low-income, mostly minority neighborhoods in Houston, Texas, looked at individuals ≥50 with significant worry and interest in psychosocial treatment. Interventions were CL, cognitive behavioral therapy with resource counseling, facilitation of communication with primary care providers about worry/anxiety, integration of religion/spirituality, person-centered skill content and delivery and nontraditional community providers, ECC-RC, and enhanced standard community-based information/ resource counseling addressing basic unmet and mental health needs. Primary outcomes were worry and GAD-related symptom severity. Secondary outcomes were anxiety, depression, sleep difficulties, trauma-related symptoms, functional status, quality of life, service use and satisfaction.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Similar, moderate improvements followed CL and ECC-RC on worry, GAD-related symptoms, anxiety, depression, sleep, trauma-related symptoms, and mental health quality of life at 6 and 9 months, but with symptoms at both times and higher satisfaction with CL at both. Fewer ECC-RC participants reported a hospital admission in the prior 3 months than those in CL at 6 and 9 months; at 9 months, fewer reported a visit with a provider in the previous 3 months.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both interventions showed similar improvements at 6 and 9 months, but symptoms remained that might require care. Either intervention or a combination may be useful for low-income older adults with identified worry/anxiety.</AbstractText>                <CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Stanley</LastName>                    <ForeName>Melinda A</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>HSR&amp;D Center for Innovations in Quality, Effectiveness and Safety (MAS, NLW, ABA, PW, TLF, MEK), Michael E. DeBakey VA Medical Center, Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston; the VA South Central Mental Illness Research, Education and Clinical Center (MAS, TLF, MEK), Houston. Electronic address: mstanley@bcm.tmc.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wilson</LastName>                    <ForeName>Nancy L</ForeName>                    <Initials>NL</Initials>                    <AffiliationInfo>                        <Affiliation>HSR&amp;D Center for Innovations in Quality, Effectiveness and Safety (MAS, NLW, ABA, PW, TLF, MEK), Michael E. DeBakey VA Medical Center, Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shrestha</LastName>                    <ForeName>Srijana</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>St. Thomas University (SS), Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Amspoker</LastName>                    <ForeName>Amber B</ForeName>                    <Initials>AB</Initials>                    <AffiliationInfo>                        <Affiliation>HSR&amp;D Center for Innovations in Quality, Effectiveness and Safety (MAS, NLW, ABA, PW, TLF, MEK), Michael E. DeBakey VA Medical Center, Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wagener</LastName>                    <ForeName>Paula</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>HSR&amp;D Center for Innovations in Quality, Effectiveness and Safety (MAS, NLW, ABA, PW, TLF, MEK), Michael E. DeBakey VA Medical Center, Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bavineau</LastName>                    <ForeName>Jane</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Sheltering Arms Senior Services (JB), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Turner</LastName>                    <ForeName>Marla</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Catholic Charities (MT), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fletcher</LastName>                    <ForeName>Terri L</ForeName>                    <Initials>TL</Initials>                    <AffiliationInfo>                        <Affiliation>HSR&amp;D Center for Innovations in Quality, Effectiveness and Safety (MAS, NLW, ABA, PW, TLF, MEK), Michael E. DeBakey VA Medical Center, Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston; the VA South Central Mental Illness Research, Education and Clinical Center (MAS, TLF, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Freshour</LastName>                    <ForeName>Jessica</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Michael E. DeBakey VA Medical Center (JF, CKS), Houston, TX; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kraus-Schuman</LastName>                    <ForeName>Cynthia</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Michael E. DeBakey VA Medical Center (JF, CKS), Houston, TX; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kunik</LastName>                    <ForeName>Mark E</ForeName>                    <Initials>ME</Initials>                    <AffiliationInfo>                        <Affiliation>HSR&amp;D Center for Innovations in Quality, Effectiveness and Safety (MAS, NLW, ABA, PW, TLF, MEK), Michael E. DeBakey VA Medical Center, Houston; Baylor College of Medicine (MAS, NLW, SS, ABA, PW, TLF, JF, CKS, MEK), Houston; the VA South Central Mental Illness Research, Education and Clinical Center (MAS, TLF, MEK), Houston.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>07</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Am J Geriatr Psychiatry</MedlineTA>            <NlmUniqueID>9309609</NlmUniqueID>            <ISSNLinking>1064-7481</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">African Americans</Keyword>            <Keyword MajorTopicYN="N">Cognitive behavior therapy</Keyword>            <Keyword MajorTopicYN="N">minority</Keyword>            <Keyword MajorTopicYN="N">older adults</Keyword>            <Keyword MajorTopicYN="N">randomized controlled trial</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30224269</ArticleId>            <ArticleId IdType="pii">S1064-7481(18)30443-3</ArticleId>            <ArticleId IdType="doi">10.1016/j.jagp.2018.07.011</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30223913</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">2056-4694</ISSN>                <JournalIssue CitedMedium="Print">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>BJPsych bulletin</Title>                <ISOAbbreviation>BJPsych Bull</ISOAbbreviation>            </Journal>            <ArticleTitle>The assertive approach to clozapine: nasogastric administration.</ArticleTitle>            <Pagination>                <MedlinePgn>1-6</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1192/bjb.2018.61</ELocationID>            <Abstract>                <AbstractText>Aims and methodAn 'assertive approach' to clozapine, where nasogastric administration is approved, is assessed through a case-load analysis to provide the first systematic description of its use and outcomes worldwide.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Five of the most extremely ill patients with treatment-resistant schizophrenia were established and/or maintained on clozapine, resulting in improvements to their mental state; incidents were reduced, segregation was terminated and progression to less restrictive environments was achieved.Clinical implicationsDespite being underutilised and rarely enforced, in extreme circumstances, an assertive approach to clozapine can be justified. Nasogastric clozapine can be safely delivered and the approach itself, rather than actual nasogastric administration, may be enough to help establish and maintain patients with treatment-resistant schizophrenia on the most effective treatment.Declaration of interestE.S. has received speaker fees from Jansen Pharmaceuticals and Novartis.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Till</LastName>                    <ForeName>Alex</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5800-0017</Identifier>                    <AffiliationInfo>                        <Affiliation>Psychiatric Trainee,School of Psychiatry, Health Education North West (Mersey),UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Selwood</LastName>                    <ForeName>James</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Fellow,School of Clinical Sciences, University of Bristol,UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Silva</LastName>                    <ForeName>Edward</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Consultant Forensic Psychiatrist,Ashworth Hospital, Mersey Care NHS Foundation Trust,UK.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BJPsych Bull</MedlineTA>            <NlmUniqueID>101650950</NlmUniqueID>            <ISSNLinking>2056-4694</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Psychotic disorders</Keyword>            <Keyword MajorTopicYN="N">antipsychotics</Keyword>            <Keyword MajorTopicYN="N">clozapine</Keyword>            <Keyword MajorTopicYN="N">nasogastric administration</Keyword>            <Keyword MajorTopicYN="N">psychosis</Keyword>            <Keyword MajorTopicYN="N">schizophrenia</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30223913</ArticleId>            <ArticleId IdType="pii">S205646941800061X</ArticleId>            <ArticleId IdType="doi">10.1192/bjb.2018.61</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30223873</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1745-6215</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>19</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Trials</Title>                <ISOAbbreviation>Trials</ISOAbbreviation>            </Journal>            <ArticleTitle>An Internet-based Acceptance and Commitment Therapy intervention for older adults with anxiety complaints: study protocol for a cluster randomized controlled trial.</ArticleTitle>            <Pagination>                <MedlinePgn>502</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-018-2731-3</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Anxiety is among the most prevalent and disabling mental health problems in older adults. Few older adults with mild to moderately severe anxiety symptoms receive adequate interventions, putting them at risk for developing anxiety disorders, depression, and various somatic problems. Effective, low-threshold interventions should be developed. Blended care, in which a web-based intervention is combined with a limited amount of face-to-face contacts with a mental healthcare counselor at the general practice, is a promising option. The online self-help intervention &quot;Living to the Full&quot;-an Acceptance and Commitment Therapy (ACT) intervention-has been proven to reduce depression and anxiety in several patient groups, but has not yet been investigated in older adults. The aim of this study is to evaluate the (cost-)effectiveness of a blended form of &quot;Living to the Full&quot; in reducing anxiety symptoms in adults aged 55 to 75 years. Furthermore, moderators and mediators of the treatment effect are investigated.</AbstractText>                <AbstractText Label="METHODS/DESIGN" NlmCategory="METHODS">The (cost-)effectiveness of the ACT intervention will be investigated in a cluster single-blind randomized controlled trial (RCT). The blended intervention will be compared to treatment-as-usual. Thirty-six mental health counselors working at general practices in the Netherlands will be randomized to deliver blended care or treatment as usual. A total of 240 participants (aged 55-75 years) with mild to moderately severe anxiety complaints (defined as a total score of 5-15 on the GAD-7) will be recruited. There are four measurements consisting of online questionnaires (primary outcome: GAD-7) and a telephone interview: before the start of the intervention; directly following the intervention (14 weeks after baseline); and six and twelve months after baseline. Possible mediator variables will be assessed multiple times basis during the intervention.</AbstractText>                <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This RCT will evaluate the effectiveness of a blended ACT intervention for older adults with anxiety symptoms. If the intervention is shown to be effective, it will be implemented, thereby improving the accessibility and quality of preventive interventions for older adults with anxiety problems.</AbstractText>                <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Netherlands Trial Register, NTR6270 . Registered on 21 March 2017.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Witlox</LastName>                    <ForeName>Maartje</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9580-556X</Identifier>                    <AffiliationInfo>                        <Affiliation>Institute of Psychology, Leiden University, Leiden, The Netherlands. M.witlox@fsw.leidenuniv.nl.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kraaij</LastName>                    <ForeName>Vivivan</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Psychology, Leiden University, Leiden, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Garnefski</LastName>                    <ForeName>Nadia</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Psychology, Leiden University, Leiden, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>de Waal</LastName>                    <ForeName>Margot W M</ForeName>                    <Initials>MWM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Smit</LastName>                    <ForeName>Filip</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Netherlands Institute of Mental Health and Addiction, Trimbos, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hoencamp</LastName>                    <ForeName>Erik</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Parnassia Psychiatric Institute, The Hague, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gussekloo</LastName>                    <ForeName>Jacobijn</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Public Health and Primary Care and Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bohlmeijer</LastName>                    <ForeName>Ernst T</ForeName>                    <Initials>ET</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology Health and Technology, University of Twente, Twente, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Spinhoven</LastName>                    <ForeName>Philip</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Psychology, Leiden University, Leiden, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>531001205</GrantID>                    <Agency>ZonMw</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Trials</MedlineTA>            <NlmUniqueID>101263253</NlmUniqueID>            <ISSNLinking>1745-6215</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Acceptance and commitment therapy</Keyword>            <Keyword MajorTopicYN="N">Anxiety</Keyword>            <Keyword MajorTopicYN="N">Anxiety complaints</Keyword>            <Keyword MajorTopicYN="N">Blended care</Keyword>            <Keyword MajorTopicYN="N">Internet</Keyword>            <Keyword MajorTopicYN="N">Older adults</Keyword>            <Keyword MajorTopicYN="N">Randomized controlled trial</Keyword>            <Keyword MajorTopicYN="N">Subclinical anxiety</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>08</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30223873</ArticleId>            <ArticleId IdType="doi">10.1186/s13063-018-2731-3</ArticleId>            <ArticleId IdType="pii">10.1186/s13063-018-2731-3</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30223855</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1741-7015</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>16</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>18</Day>                    </PubDate>                </JournalIssue>                <Title>BMC medicine</Title>                <ISOAbbreviation>BMC Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Recently resettled refugee women-at-risk in Australia evidence high levels of psychiatric symptoms: individual, trauma and post-migration factors predict outcomes.</ArticleTitle>            <Pagination>                <MedlinePgn>149</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-018-1143-2</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite increasing numbers of refugee women-at-risk being resettled and their potential vulnerability, there exists no empirical research into the psychiatric health of this unique subgroup with which to guide policy and practice. This research aimed to investigate psychiatric symptom status of a sample of refugee women-at-risk recently resettled in Australia, as well as factors contributing to symptoms of trauma, anxiety, depression, and somatization. The level of psychiatric symptomatology is compared to reference groups of women from Sudan and Burma, who entered Australia under the Humanitarian Entry Programme, and who did not meet criteria as women-at-risk.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This is a cross-sectional survey of 104 refugee women-at-risk across several ethnic groups including a demographic questionnaire, the Harvard Trauma Questionnaire, Post-migration Living Difficulties Checklist, and Hopkins Symptom Checklist to assess individual factors, traumatic experiences, post-migration problems, and symptoms of trauma, anxiety, depression, and somatization. A series of multiple hierarchical regression analyses examined factors predicting psychiatric symptoms.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Substantial proportions of participants reported psychiatric distress in symptomatic ranges, including for traumatization (41%), post-traumatic stress disorder (20%), anxiety (29%), and depression (41%), as well as significant symptoms of somatization (41%). These findings are significantly higher than those derived from reference groups of women from Sudan or Burma, resettled in the same area and utilizing a similar methodology. Higher numbers of trauma events and post-migration living difficulties predicted higher trauma, depression, and somatic (but not anxiety) symptoms. Having children predicted higher trauma, anxiety, and somatic symptoms. Greater English fluency predicted higher anxiety symptoms. Region of birth predicted anxiety and depression symptoms. Age predicted trauma and anxiety symptoms.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings suggest that recently arrived refugee women-at-risk are at high risk of psychiatric disorders. The results indicate a need for comprehensive psychiatric assessment to identify women in need of treatment very early after resettlement, with implications for medical practice, service delivery, and policy programs.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Schweitzer</LastName>                    <ForeName>Robert D</ForeName>                    <Initials>RD</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9915-0786</Identifier>                    <AffiliationInfo>                        <Affiliation>School of Psychology and Counselling, Queensland University of Technology, Kelvin Grove, QLD, 4067, Australia. r.schweitzer@qut.edu.au.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vromans</LastName>                    <ForeName>Lyn</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>School of Psychology and Counselling, Queensland University of Technology, Kelvin Grove, QLD, 4067, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brough</LastName>                    <ForeName>Mark</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>School of Public Health and Social Work, Queensland University of Technology, Kelvin Grove, QLD, 4067, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Asic-Kobe</LastName>                    <ForeName>Mary</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Access Community Services Ltd, Logan Central, QLD, 4114, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Correa-Velez</LastName>                    <ForeName>Ignacio</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>School of Public Health and Social Work, Queensland University of Technology, Kelvin Grove, QLD, 4067, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Murray</LastName>                    <ForeName>Kate</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>School of Psychology and Counselling, Queensland University of Technology, Kelvin Grove, QLD, 4067, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lenette</LastName>                    <ForeName>Caroline</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Forced Migration Research Network, School of Social Sciences, University of New South Wales, Sydney, NSW, 2006, Australia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>LP140100609</GrantID>                    <Agency>Australian Research Council</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Med</MedlineTA>            <NlmUniqueID>101190723</NlmUniqueID>            <ISSNLinking>1741-7015</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Mental health</Keyword>            <Keyword MajorTopicYN="N">Post-migration living difficulties</Keyword>            <Keyword MajorTopicYN="N">Refugee</Keyword>            <Keyword MajorTopicYN="N">Trauma</Keyword>            <Keyword MajorTopicYN="N">Women</Keyword>            <Keyword MajorTopicYN="N">Women-at-risk</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>08</Month>                <Day>31</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30223855</ArticleId>            <ArticleId IdType="doi">10.1186/s12916-018-1143-2</ArticleId>            <ArticleId IdType="pii">10.1186/s12916-018-1143-2</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30223409</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1875-9270</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>08</Day>                    </PubDate>                </JournalIssue>                <Title>Work (Reading, Mass.)</Title>                <ISOAbbreviation>Work</ISOAbbreviation>            </Journal>            <ArticleTitle>Concordance of assessments of clients' mental and behavioral health with in vivo assessment of work performance.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.3233/WOR-182776</ELocationID>            <Abstract>                <AbstractText>BackgroundAssessing functioning and disability among individuals with mental and behavioral health disorders has historically relied on deriving accurate psychiatric diagnoses and assessing symptoms. However, growing empirical evidence suggests that this approach is inadequate to determine real world performance, particularly with respect to work.ObjectiveWe examined a performance-based approach to the assessment of work functioning and its relationship to mental and behavioral health status.MethodsA cross-sectional study was conducted at two mental health programs. Trained employment providers conducted performance-based assessments of work function and ratings of mental and behavioral health while study participants self-reported their mental/behavioral health functioning. We hypothesized that participant and provider ratings of mental/behavioral health would be at moderately correlated and with performance-based assessments of work function.ResultsWe found no significant correlation between participants' self-report of their mental and behavioral health and performance-based assessments of work. Employment providers' ratings of participants' mental/behavioral health were moderately correlated with performance-based measures of work. Finally, we found low concordance between employment providers and study participants' with respect to ratings of their mental/behavioral health.ConclusionsContrary to our hypotheses, ratings of mental/behavioral health were only moderately correlated to performance-based measures of work. Results confirm earlier research suggesting that it is difficult to predict work performance from participants' self-reports of their mental/behavioral health alone. Performance-based assessments of work capacity as well as ratings of mental and behavioral health may both be needed for a more complete and complimentary picture of the ability of individuals with mental and behavioral health disorders to function in the work place.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Rogers</LastName>                    <ForeName>E Sally</ForeName>                    <Initials>ES</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Psychiatric Rehabilitation, Sargent College, Boston University, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Millner</LastName>                    <ForeName>Uma Chandrika</ForeName>                    <Initials>UC</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Psychiatric Rehabilitation, Sargent College, Boston University, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brandt</LastName>                    <ForeName>Diane</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Rehabilitation Medicine, National Institutes of Health, Bethesda, MD, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chan</LastName>                    <ForeName>Leighton</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Rehabilitation Medicine, National Institutes of Health, Bethesda, MD, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jette</LastName>                    <ForeName>Alan</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Health and Disability Research Institute, School of Public Health, Boston University, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Marfeo</LastName>                    <ForeName>Elizabeth</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Occupational Therapy, Tufts University, Medford, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ni</LastName>                    <ForeName>Pengsheng</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Health and Disability Research Institute, School of Public Health, Boston University, Boston, MA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rasch</LastName>                    <ForeName>Elizabeth</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Rehabilitation Medicine, National Institutes of Health, Bethesda, MD, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>08</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Work</MedlineTA>            <NlmUniqueID>9204382</NlmUniqueID>            <ISSNLinking>1051-9815</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30223409</ArticleId>            <ArticleId IdType="pii">WOR182776</ArticleId>            <ArticleId IdType="doi">10.3233/WOR-182776</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedBookArticle>    <BookDocument>        <PMID Version="1">30222285</PMID>        <ArticleIdList>            <ArticleId IdType="bookaccession">NBK525339</ArticleId>            <ArticleId IdType="doi">10.3310/pgfar06060</ArticleId>        </ArticleIdList>        <Book>            <Publisher>                <PublisherName>NIHR Journals Library</PublisherName>                <PublisherLocation>Southampton (UK)</PublisherLocation>            </Publisher>            <BookTitle book="ukpgfar0606">Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care – the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Suicidality) programme</BookTitle>            <PubDate>                <Year>2018</Year>                <Month>9</Month>            </PubDate>            <AuthorList Type="authors">                <Author>                    <LastName>Jones</LastName>                    <ForeName>Steven</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Spectrum Centre for Mental Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Riste</LastName>                    <ForeName>Lisa</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>School of Psychological Sciences, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Barrowclough</LastName>                    <ForeName>Christine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>School of Psychological Sciences, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Bartlett</LastName>                    <ForeName>Peter</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>School of Law and Institute of Mental Health, University of Nottingham, Nottingham, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Clements</LastName>                    <ForeName>Caroline</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Davies</LastName>                    <ForeName>Linda</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Population Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Holland</LastName>                    <ForeName>Fiona</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Population Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Kapur</LastName>                    <ForeName>Nav</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Manchester Mental Health &amp; Social Care NHS Trust, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Lobban</LastName>                    <ForeName>Fiona</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Spectrum Centre for Mental Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Long</LastName>                    <ForeName>Rita</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Spectrum Centre for Mental Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Morriss</LastName>                    <ForeName>Richard</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Mental Health, University of Nottingham, Nottingham, UK</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Peters</LastName>                    <ForeName>Sarah</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>School of Psychological Sciences, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Roberts</LastName>                    <ForeName>Chris</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Population Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Camacho</LastName>                    <ForeName>Elizabeth</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Population Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Gregg</LastName>                    <ForeName>Lynsey</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>School of Psychological Sciences, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>                <Author>                    <LastName>Ntais</LastName>                    <ForeName>Dionysios</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Population Health, University of Manchester, Manchester, UK</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <CollectionTitle book="ukpgfarcollect">Programme Grants for Applied Research</CollectionTitle>            <ELocationID EIdType="doi">10.3310/pgfar06060</ELocationID>        </Book>        <Language>eng</Language>        <PublicationType UI="D016454">Review</PublicationType>        <Abstract>            <AbstractText Label="BACKGROUND">Bipolar disorder (BD) costs £5.2B annually, largely as a result of incomplete recovery after inadequate treatment.</AbstractText>            <AbstractText Label="OBJECTIVES">A programme of linked studies to reduce relapse and suicide in BD.</AbstractText>            <AbstractText Label="DESIGN">There were five workstreams (WSs): a pragmatic randomised controlled trial (RCT) of group psychoeducation (PEd) versus group peer support (PS) in the maintenance of BD (WS1); development and feasibility RCTs of integrated psychological therapy for anxiety in bipolar disorder (AIBD) and integrated for problematic alcohol use in BD (WS2 and WS3); survey and qualitative investigations of suicide and self-harm in BD (WS4); and survey and qualitative investigation of service users’ (SUs) and psychiatrists’ experience of the Mental Capacity Act 2005 (MCA), with reference to advance planning (WS5).</AbstractText>            <AbstractText Label="SETTING">Participants were from England; recruitment into RCTs was limited to certain sites [East Midlands and North West (WS1); North West (WS2 and WS3)].</AbstractText>            <AbstractText Label="PARTICIPANTS">Aged ≥ 18 years. In WS1–3, participants had their diagnosis of BD confirmed by the Structural Clinical Interview for the <i>Diagnostic and Statistical Manual of Mental Disorders</i>.</AbstractText>            <AbstractText Label="INTERVENTIONS">In WS1, group PEd/PS; in WS3 and WS4, individual psychological therapy for comorbid anxiety and alcohol use, respectively.</AbstractText>            <AbstractText Label="MAIN OUTCOME MEASURES">In WS1, time to relapse of bipolar episode; in WS2 and WS3, feasibility and acceptability of interventions; in WS4, prevalence and determinants of suicide and self-harm; and in WS5, professional training and support of advance planning in MCA, and SU awareness and implementation.</AbstractText>            <AbstractText Label="RESULTS">Group PEd and PS could be routinely delivered in the NHS. The estimated median time to first bipolar relapse was 67.1 [95% confidence interval (CI) 37.3 to 90.9] weeks in PEd, compared with 48.0 (95% CI 30.6 to 65.9) weeks in PS. The adjusted hazard ratio was 0.83 (95% CI 0.62 to 1.11; likelihood ratio test <i>p</i> = 0.217). The interaction between the number of previous bipolar episodes (1–7 and 8–19, relative to 20+) and treatment arm was significant (χ<sup>2</sup> = 6.80, degrees of freedom = 2; <i>p</i> = 0.034): PEd with one to seven episodes showed the greatest delay in time to episode. A primary economic analysis indicates that PEd is not cost-effective compared with PS. A sensitivity analysis suggests potential cost-effectiveness if decision-makers accept a cost of £37,500 per quality-adjusted life-year. AIBD and motivational interviewing (MI) cognitive–behavioural therapy (CBT) trials were feasible and acceptable in achieving recruitment and retention targets (AIBD: <i>n</i> = 72, 72% retention to follow-up; MI-CBT: <i>n</i> = 44, 75% retention) and in-depth qualitative interviews. There were no significant differences in clinical outcomes for either trial overall. The factors associated with risk of suicide and self-harm (longer duration of illness, large number of periods of inpatient care, and problems establishing diagnosis) could inform improved clinical care and specific interventions. Qualitative interviews suggested that suicide risk had been underestimated, that care needs to be more collaborative and that people need fast access to good-quality care. Despite SUs supporting advance planning and psychiatrists being trained in MCA, the use of MCA planning provisions was low, with confusion over informal and legally binding plans.</AbstractText>            <AbstractText Label="LIMITATIONS">Inferences for routine clinical practice from WS1 were limited by the absence of a ‘treatment as usual’ group.</AbstractText>            <AbstractText Label="CONCLUSION">The programme has contributed significantly to understanding how to improve outcomes in BD. Group PEd is being implemented in the NHS influenced by SU support.</AbstractText>            <AbstractText Label="FUTURE WORK">Future work is needed to evaluate optimal approaches to psychological treatment of comorbidity in BD. In addition, work in improved risk detection in relation to suicide and self-harm in clinical services and improved training in MCA are indicated.</AbstractText>            <AbstractText Label="TRIAL REGISTRATION">Current Controlled Trials ISRCTN62761948, ISRCTN84288072 and ISRCTN14774583.</AbstractText>            <AbstractText Label="FUNDING">This project was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research programme and will be published in full in <i>Programme Grants for Applied Research</i>; Vol. 6, No. 6. See the NIHR Journals Library website for further project information.</AbstractText>            <CopyrightInformation>Copyright © Queen’s Printer and Controller of HMSO 2018. This work was produced by Jones et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.</CopyrightInformation>        </Abstract>        <Sections>            <Section>                <SectionTitle book="ukpgfar0606" part="abs2">Plain English summary</SectionTitle>            </Section>            <Section>                <SectionTitle book="ukpgfar0606" part="abs3">Scientific summary</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 1</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s1">Introduction</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 2a</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s2a">Pragmatic randomised controlled trial of group psychoeducation versus group peer support in the maintenance of bipolar disorder: main clinical outcomes</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 2b</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s2b">Pragmatic randomised controlled trial of psychoeducation versus peer support in the maintenance of bipolar disorder: economic evaluation</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 3</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s3">Psychological treatment of anxiety in bipolar disorder</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 4</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s4">Psychological treatment of comorbid alcohol use in bipolar disorder</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 5</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s5">Suicidal behaviour in bipolar disorder</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 6</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s6">Is the Mental Capacity Act changing clinical practice for patients with bipolar disorder?</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 7</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s7">Service user involvement in the PARADES programme</SectionTitle>            </Section>            <Section>                <LocationLabel Type="chapter">Chapter 8</LocationLabel>                <SectionTitle book="ukpgfar0606" part="s8">Discussion</SectionTitle>            </Section>            <Section>                <SectionTitle book="ukpgfar0606" part="ack1">Acknowledgements</SectionTitle>            </Section>            <Section>                <SectionTitle book="ukpgfar0606" part="ref1">References</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 1</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app1">Additional participant details</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 2</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app2">Utility and quality-adjusted life-years data</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 3</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app3">Service use and costs</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 4</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app4">Mental Capacity Act 2005 study: psychiatrists’ survey</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 5</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app5">Advance planning for people with bipolar disorder</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 6</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app6">Mental Capacity Act 2005 study: service user survey</SectionTitle>            </Section>            <Section>                <LocationLabel Type="appendix">Appendix 7</LocationLabel>                <SectionTitle book="ukpgfar0606" part="app7">Integrated anxiety intervention-specific fidelity measure</SectionTitle>            </Section>            <Section>                <SectionTitle book="ukpgfar0606" part="g1">List of abbreviations</SectionTitle>            </Section>        </Sections>    </BookDocument>    <PubmedBookData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222285</ArticleId>        </ArticleIdList>    </PubmedBookData></PubmedBookArticle><PubmedBookArticle>    <BookDocument>        <PMID Version="1">30222276</PMID>        <ArticleIdList>            <ArticleId IdType="bookaccession">NBK525600</ArticleId>        </ArticleIdList>        <Book>            <Publisher>                <PublisherName>Canadian Agency for Drugs and Technologies in Health</PublisherName>                <PublisherLocation>Ottawa (ON)</PublisherLocation>            </Publisher>            <BookTitle book="rc0922">Smoking Cessation Interventions for Patients with Severe Mental Illnesses: A Review of Clinical Effectiveness and Guidelines</BookTitle>            <PubDate>                <Year>2017</Year>                <Month>08</Month>                <Day>24</Day>            </PubDate>            <AuthorList Type="authors">                <Author>                    <LastName>Jahagirdar</LastName>                    <ForeName>Deepa</ForeName>                    <Initials>D</Initials>                </Author>                <Author>                    <LastName>Kaunelis</LastName>                    <ForeName>David</ForeName>                    <Initials>D</Initials>                </Author>            </AuthorList>            <CollectionTitle book="cadthrdcollect">CADTH Rapid Response Reports</CollectionTitle>            <Medium>Internet</Medium>        </Book>        <Language>eng</Language>        <PublicationType UI="D016454">Review</PublicationType>        <Abstract>            <AbstractText>Treatment may be able to lessen the significant burden and associated risks of smoking among people with mental illness, but concerns about effectiveness and safety may limit its potential. To inform decisions about using pharmacotherapy among those with mental illness, specific evidence is thus required. As such, this rapid review summarizes the evidence on the effectiveness and evidence-based guidelines on smoking cessation intervention among those with severe mental illness.</AbstractText>            <CopyrightInformation>Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.</CopyrightInformation>        </Abstract>    </BookDocument>    <PubmedBookData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222276</ArticleId>        </ArticleIdList>    </PubmedBookData></PubmedBookArticle><PubmedBookArticle>    <BookDocument>        <PMID Version="1">30222274</PMID>        <ArticleIdList>            <ArticleId IdType="bookaccession">NBK525628</ArticleId>        </ArticleIdList>        <Book>            <Publisher>                <PublisherName>Canadian Agency for Drugs and Technologies in Health</PublisherName>                <PublisherLocation>Ottawa (ON)</PublisherLocation>            </Publisher>            <BookTitle book="rc0931">Adapted or Tailored Psychological Interventions for Treating Women with Mental Illness: A Review of Clinical Effectiveness and Guidelines</BookTitle>            <PubDate>                <Year>2017</Year>                <Month>10</Month>                <Day>05</Day>            </PubDate>            <AuthorList Type="authors">                <Author>                    <LastName>Williams</LastName>                    <ForeName>D.</ForeName>                    <Initials>D</Initials>                </Author>                <Author>                    <LastName>Mierzwinski-Urban</LastName>                    <ForeName>Monika</ForeName>                    <Initials>M</Initials>                </Author>            </AuthorList>            <CollectionTitle book="cadthrdcollect">CADTH Rapid Response Reports</CollectionTitle>            <Medium>Internet</Medium>        </Book>        <Language>eng</Language>        <PublicationType UI="D016454">Review</PublicationType>        <Abstract>            <AbstractText>The purpose of this review is to provide evidence surrounding the effectiveness of psychological interventions that are adapted or tailored to women for the treatment of anxiety disorders (including posttraumatic stress disorder), depressive disorders, and substance-related and addictive disorders, and to identify relevant evidence-based guidelines.</AbstractText>            <CopyrightInformation>Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.</CopyrightInformation>        </Abstract>    </BookDocument>    <PubmedBookData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222274</ArticleId>        </ArticleIdList>    </PubmedBookData></PubmedBookArticle><PubmedBookArticle>    <BookDocument>        <PMID Version="1">30222270</PMID>        <ArticleIdList>            <ArticleId IdType="bookaccession">NBK525629</ArticleId>        </ArticleIdList>        <Book>            <Publisher>                <PublisherName>Canadian Agency for Drugs and Technologies in Health</PublisherName>                <PublisherLocation>Ottawa (ON)</PublisherLocation>            </Publisher>            <BookTitle book="rc0937">Dialectical Behavioral Therapy for Adults with Mental Illness: A Review of Clinical Effectiveness and Guidelines</BookTitle>            <PubDate>                <Year>2017</Year>                <Month>10</Month>                <Day>20</Day>            </PubDate>            <AuthorList Type="authors">                <Author>                    <LastName>Peprah</LastName>                    <ForeName>Kwakye</ForeName>                    <Initials>K</Initials>                </Author>                <Author>                    <LastName>Argáez</LastName>                    <ForeName>Charlene</ForeName>                    <Initials>C</Initials>                </Author>            </AuthorList>            <CollectionTitle book="cadthrdcollect">CADTH Rapid Response Reports</CollectionTitle>            <Medium>Internet</Medium>        </Book>        <Language>eng</Language>        <PublicationType UI="D016454">Review</PublicationType>        <Abstract>            <AbstractText>This review aims to summarize evidence regarding the clinical effectiveness and guidelines for the use of Dialectical Behavioral Therapy (DBT) in the treatment of adult patients with mental illness.</AbstractText>            <CopyrightInformation>Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.</CopyrightInformation>        </Abstract>    </BookDocument>    <PubmedBookData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222270</ArticleId>        </ArticleIdList>    </PubmedBookData></PubmedBookArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30223263</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1423-0224</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Neuropsychobiology</Title>                <ISOAbbreviation>Neuropsychobiology</ISOAbbreviation>            </Journal>            <ArticleTitle>The Role of Nutrition and the Gut-Brain Axis in Psychiatry: A Review of the Literature.</ArticleTitle>            <Pagination>                <MedlinePgn>1-9</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000492834</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Individuals suffering from psychiatric disorders experience high levels of illness burden and a significantly reduced quality of life. Despite targeted psychopharmacological strategies and complementary psychotherapeutic procedures only moderate effects are obtained, and the risk of relapse is high in many patients. Worldwide, psychiatric diseases such as depression are continuously increasing, challenging the personal life of the affected as well as their families, but also whole societies by increasing disability, early retirement and hospitalization. According to current scientific knowledge psychiatric disorders are caused by a multifactorial pathogenesis, including genetics, inflammation and neurotransmitter imbalance; furthermore, also lifestyle-associated factors gain rising importance. In line with this, there is growing evidence that the gut microbiota and nutrition have an impact on the onset and course of psychiatric disorders.</AbstractText>                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">This narrative review highlights the important role of nutrition in psychiatric care and underlines the significance of nutritional advice in the multifactorial, biopsychosocial treatment of patients. It focuses on current dietary interventions such as the Mediterranean diet, dietary supplements and modifications of the gut microbiota with pre-, pro- and postbiotics.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Recent studies support the connection between the quality of diet, gut microbiota and mental health through regulation of metabolic functions, anti-inflammatory and antiapoptotic properties and the support of neurogenesis. Dietary coaching to improve mental health seems to be an additional, cost-effective, practical, nonpharmacological intervention for individuals with psychiatric disorders.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of nutritional interventions in psychiatry equips therapists with a promising tool for both the prevention and treatment of psychiatric disorders. Besides pharmacological therapy, psychotherapy and physical activity, nutritional interventions are an important pillar in the multifactorial, biopsychosocial treatment of psychiatric disease and could be used as a potential therapeutic target.</AbstractText>                <CopyrightInformation>© 2018 S. Karger AG, Basel.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Mörkl</LastName>                    <ForeName>Sabrina</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wagner-Skacel</LastName>                    <ForeName>Jolana</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lahousen</LastName>                    <ForeName>Theresa</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lackner</LastName>                    <ForeName>Sonja</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Immunology and Pathophysiology, Otto Loewi Research Center (for Vascular Biology, Immunology and Inflammation), Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Holasek</LastName>                    <ForeName>Sandra Johanna</ForeName>                    <Initials>SJ</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Immunology and Pathophysiology, Otto Loewi Research Center (for Vascular Biology, Immunology and Inflammation), Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bengesser</LastName>                    <ForeName>Susanne Astrid</ForeName>                    <Initials>SA</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Painold</LastName>                    <ForeName>Annamaria</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Holl</LastName>                    <ForeName>Anna Katharina</ForeName>                    <Initials>AK</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Reininghaus</LastName>                    <ForeName>Eva</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Neuropsychobiology</MedlineTA>            <NlmUniqueID>7512895</NlmUniqueID>            <ISSNLinking>0302-282X</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Depression</Keyword>            <Keyword MajorTopicYN="N">Diet</Keyword>            <Keyword MajorTopicYN="N">Gut microbiome</Keyword>            <Keyword MajorTopicYN="N">Gut-brain axis</Keyword>            <Keyword MajorTopicYN="N">Mediterranean diet</Keyword>            <Keyword MajorTopicYN="N">Nutrients</Keyword>            <Keyword MajorTopicYN="N">Nutrition</Keyword>            <Keyword MajorTopicYN="N">Psychiatry</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30223263</ArticleId>            <ArticleId IdType="pii">000492834</ArticleId>            <ArticleId IdType="doi">10.1159/000492834</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30222188</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1532-6535</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>104</Volume>                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Clinical pharmacology and therapeutics</Title>                <ISOAbbreviation>Clin. Pharmacol. Ther.</ISOAbbreviation>            </Journal>            <ArticleTitle>Treating a Child With Mental Illness.</ArticleTitle>            <Pagination>                <MedlinePgn>592-594</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cpt.1182</ELocationID>            <Abstract>                <AbstractText>Drug treatment of attention-deficit hyperactivity disorder (ADHD) with stimulants, such as methylphenidate, has been widespread across the developed countries and is also becoming common in adults. However, this seemingly effective treatment is not without controversy on the evidence that supports their use. In addition, disparities in the frequency of its use across the world are tremendous. Although stimulants are one of the standard therapies for ADHD, autism spectrum disorder (ASD) lacks such a drug treatment. Focusing on neurogenetic conditions with defined genetic abnormalities, which have ASD as a co-existing symptom, a search for a druggable target of ASD continues.</AbstractText>                <CopyrightInformation>© 2018 American Society for Clinical Pharmacology and Therapeutics.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ito</LastName>                    <ForeName>Shinya</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Paediatrics, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016421">Editorial</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Clin Pharmacol Ther</MedlineTA>            <NlmUniqueID>0372741</NlmUniqueID>            <ISSNLinking>0009-9236</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222188</ArticleId>            <ArticleId IdType="doi">10.1002/cpt.1182</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30222057</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1532-530X</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Eating disorders</Title>                <ISOAbbreviation>Eat Disord</ISOAbbreviation>            </Journal>            <ArticleTitle>Pathways into treatment for eating disorders: A quantitative examination of treatment barriers and treatment attitudes.</ArticleTitle>            <Pagination>                <MedlinePgn>1-19</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1080/10640266.2018.1518086</ELocationID>            <Abstract>                <AbstractText>Most individuals with eating disorders do not receive treatment for their eating disorder. Closing this &quot;treatment gap&quot; requires a quantitative examination of individuals' attitudes towards accessing various types of treatment and of individuals' perceived barriers to seeking treatment. Thus, we recruited a sample of 425 individuals with either diagnosed or undiagnosed eating disorders and asked them to complete a survey assessing treatment attitudes, treatment barriers, and eating disorder symptom severity. Undiagnosed individuals reported more positive attitudes towards novel Internet- and smartphone-delivered treatments, and stronger barriers relating to eating disorders mental health literacy, than diagnosed individuals. Nevertheless, both diagnosed and undiagnosed individuals were broadly more positive towards established (i.e., non-novel) treatments than novel treatments. The strongest barriers to seeking treatment were fear of losing control, fear of change, and finding motivation to change. Eating disorder symptoms were positively associated with the strength of most treatment barriers. Results were broadly unchanged after adjusting for individuals' past experiences of treatment. In conclusion, the development and dissemination of novel treatments and the provision of eating disorders mental health literacy may offer promising potential pathways into treatment for individuals with undiagnosed eating disorders. Nevertheless, researchers must pay attention and improve, individuals' attitudes towards accessing these novel treatments. The positive correlations of symptom severity with treatment barrier strength highlights the importance of early intervention for individuals with eating disorders. Finally, the fear of losing control may be a uniquely salient treatment barrier for individuals with eating disorders that requires greater attention in future research on eating disorder treatment seeking.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Griffiths</LastName>                    <ForeName>Scott</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>a Melbourne School of Psychological Sciences , University of Melbourne , Melbourne , Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rossell</LastName>                    <ForeName>Susan L</ForeName>                    <Initials>SL</Initials>                    <AffiliationInfo>                        <Affiliation>b Centre for Mental Health, Faculty of Health Arts and Design , Swinburne University , Melbourne , Australia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>c Psychiatry , St Vincent's Hospital , Melbourne , Australia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>d Monash Alfred Psychiatry Research Centre , Central Clinical School Monash University and Alfred Hospital , Melbourne , Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mitchison</LastName>                    <ForeName>Deborah</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>e Department of Psychology , Macquarie University , Sydney , Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Murray</LastName>                    <ForeName>Stuart B</ForeName>                    <Initials>SB</Initials>                    <AffiliationInfo>                        <Affiliation>f Department of Psychiatry , University of California San Francisco , San Francisco , CA , USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mond</LastName>                    <ForeName>Jonathan M</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>g Centre for Rural Health , University of Tasmania , Launceston , Australia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>h Centre for Health Research , Western Sydney University , Sydney , Australia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Eat Disord</MedlineTA>            <NlmUniqueID>9315161</NlmUniqueID>            <ISSNLinking>1064-0266</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222057</ArticleId>            <ArticleId IdType="doi">10.1080/10640266.2018.1518086</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30221773</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1440-1630</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Australian occupational therapy journal</Title>                <ISOAbbreviation>Aust Occup Ther J</ISOAbbreviation>            </Journal>            <ArticleTitle>Learning from consumers: An eDelphi study of Australian mental health consumers' priorities for recovery-oriented curricula.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/1440-1630.12518</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Mental health reform in Australia emphasises recovery, partnership working and prioritises consumers' needs over professionals'. Occupational therapy students must develop capabilities for working in this way. Learning from consumers' lived experience of mental illness and recovery is considered critical to developing such capabilities and aligns with occupational therapy programme accreditation for consumer involvement in designing, delivering and evaluating curricula. No definitive capability standards exist to inform curricula and little is known about Australian mental health consumers' preferred modes of involvement in health professional education. This study sought to identify consumers' priorities for curricula, and ways in which they would like to participate in entry-level student education.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">An eDelphi study utilising the Policy Delphi approach was employed. Consensus by 70% of participants was set as the standard for item inclusion. The first round asked open questions about participants' priorities for recovery-oriented curricula, their experiences with mental health workers and asked participants to identify their preferred methods of participating in education. Items generated were rated in subsequent rounds until consensus was reached in round three.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-eight participants completed round one, 18 completed round two and 14 completed round three. Five core values and 171 curriculum priorities, forming 12 capability domains, reached consensus. Each capability domain comprised knowledge and understanding; skills and abilities; and behaviours and actions. Ten ways of participating in mental health curricula in entry-level occupational therapy programmes were identified, with an emphasis on active participation in design, delivery and review of curricula.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings highlight important capabilities from consumers' perspectives, suggesting key content for curricula. Active roles in designing, delivering and evaluating curricula were preferred, providing some guidance for educators seeking to involve consumers. Further research is required to refine these priorities, and to evaluate acceptability, feasibility and efficacy of varying modes of consumer involvement.</AbstractText>                <CopyrightInformation>© 2018 Occupational Therapy Australia.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Arblaster</LastName>                    <ForeName>Karen</ForeName>                    <Initials>K</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4999-2894</Identifier>                    <AffiliationInfo>                        <Affiliation>Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Mental Health Service, Nepean Blue Mountains Local Health District, Penrith, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>School of Science and Health, Western Sydney University, Penrith, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mackenzie</LastName>                    <ForeName>Lynette</ForeName>                    <Initials>L</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1597-2051</Identifier>                    <AffiliationInfo>                        <Affiliation>Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Matthews</LastName>                    <ForeName>Lynda</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Willis</LastName>                    <ForeName>Karen</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>La Trobe University, Melbourne, Victoria, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gill</LastName>                    <ForeName>Katherine</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Consumer Led Research Network, Sydney, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hanlon</LastName>                    <ForeName>Paula</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Ryde Mental Health Service, Ryde, New South Wales, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Laidler</LastName>                    <ForeName>Rachael</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Headspace National Youth Mental Health Foundation Ltd, Bruce, Australian Capital Territory, Australia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Australia</Country>            <MedlineTA>Aust Occup Ther J</MedlineTA>            <NlmUniqueID>15420200R</NlmUniqueID>            <ISSNLinking>0045-0766</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Delphi Technique</Keyword>            <Keyword MajorTopicYN="N">mental health</Keyword>            <Keyword MajorTopicYN="N">occupational therapy education</Keyword>            <Keyword MajorTopicYN="N">participatory research</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30221773</ArticleId>            <ArticleId IdType="doi">10.1111/1440-1630.12518</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30221558</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1744-8360</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>15</Day>                    </PubDate>                </JournalIssue>                <Title>Expert review of neurotherapeutics</Title>                <ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation>            </Journal>            <ArticleTitle>Deep brain stimulation for childhood dystonia: current evidence and emerging practice.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14737175.2018.1523721</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Dystonia, one of the most common childhood movement disorders, is often medically refractory and can lead to profound impacts on the child and their caretakers' quality of life. Limited efficacy of pharmacological treatments has fueled enthusiasm for innovative neurosurgical approaches, notably deep brain stimulation (DBS) as a treatment for refractory dystonia. Areas covered: DBS is increasingly applied to successfully treat childhood dystonia. While generally safe and effective, results vary widely depending on underlying dystonia etiology. The current work synthesizes and highlights advances in research pertaining to the use of DBS for childhood dystonia. The efficacy of DBS for children and youth with dystonia is discussed, with analysis divided among etiological subtypes. The role of DBS as a lifesaving treatment for status dystonicus is also reviewed. Expert Commentary: When carefully selected, certain children and youth with dystonia experience significant symptomatic improvement after DBS. Beyond dystonic symptoms, DBS can improve quality of life and reduce caretaker burden.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Elkaim</LastName>                    <ForeName>Lior M</ForeName>                    <Initials>LM</Initials>                    <AffiliationInfo>                        <Affiliation>a Faculty of Medicine , Université de Montréal , Montreal , Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>De Vloo</LastName>                    <ForeName>Phillippe</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>c Department of Neurosurgery , Great Ormond Street Hospital for Children , London , UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kalia</LastName>                    <ForeName>Suneil K</ForeName>                    <Initials>SK</Initials>                    <AffiliationInfo>                        <Affiliation>b Division of Neurosurgery, Department of Surgery , University of Toronto , Toronto , Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>d Division of Neurosurgery , Krembil Neuroscience Centre, Toronto Western Hospital , Toronto , Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lozano</LastName>                    <ForeName>Andres M</ForeName>                    <Initials>AM</Initials>                    <AffiliationInfo>                        <Affiliation>b Division of Neurosurgery, Department of Surgery , University of Toronto , Toronto , Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>d Division of Neurosurgery , Krembil Neuroscience Centre, Toronto Western Hospital , Toronto , Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ibrahim</LastName>                    <ForeName>George M</ForeName>                    <Initials>GM</Initials>                    <AffiliationInfo>                        <Affiliation>b Division of Neurosurgery, Department of Surgery , University of Toronto , Toronto , Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>e Division of Neurosurgery , The Hospital for Sick Children, Program in Neuroscience and Mental Health, The Hospital for Sick Children Research Institute , Toronto , Canada.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>15</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Expert Rev Neurother</MedlineTA>            <NlmUniqueID>101129944</NlmUniqueID>            <ISSNLinking>1473-7175</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">DBS</Keyword>            <Keyword MajorTopicYN="N">childhood dystonia</Keyword>            <Keyword MajorTopicYN="N">deep brain stimulation</Keyword>            <Keyword MajorTopicYN="N">pediatric dystonia</Keyword>            <Keyword MajorTopicYN="N">status dystonicus</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30221558</ArticleId>            <ArticleId IdType="doi">10.1080/14737175.2018.1523721</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30221438</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1479-8301</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</Title>                <ISOAbbreviation>Psychogeriatrics</ISOAbbreviation>            </Journal>            <ArticleTitle>Randomized controlled study on the effectiveness of animal-assisted therapy on depression, anxiety, and illness perception in institutionalized elderly.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/psyg.12367</ELocationID>            <Abstract>                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this study was to verify dog-assisted therapy's effectiveness on depression and anxiety in institutionalized elderly. Patients' illness perception was examined to identify core beliefs regarding mood, personal control, and illness coherence because they can affect treatment compliance. Subjective perception of pain, social interaction, and setting-bound observable variables were also studied.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This study involved a randomized sample of institutionalized patients 65 years of age and older; the treatment group had 17 subjects and the control group had 14 subjects. All patients were administered the Mini-Mental State Examination, 15-item Geriatric Depression Scale, Positive and Negative Affect Schedule, Generalized Anxiety Disorder 7, Illness Perception Questionnaire, and Numeric Pain Rating Scale. Intra- and inter-group data analysis was performed before and after treatment. Over the course of 10 weeks, patients participated in individual 30-min sessions. An observational methodology was developed to record verbal and non-verbal interactions between the elderly, the dog, and the dog handler.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A large effect size and a statistically significant decrease in 15-item Geriatric Depression Scale scores were identified in the treatment group. No significant differences were detected in the Generalized Anxiety Disorder 7, Positive and Negative Affect Schedule, and Numeric Pain Rating Scale. However, the Positive and Negative Affect Schedule and the Numeric Pain Rating Scale showed a moderate decrease. The Illness Perception Questionnaire's timeline (acute/chronic) and treatment control subscales showed a clinically relevant, large effect size.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dog-assisted therapy has proved to be effective in reducing symptoms of depression in institutionalized elderly. The increase in verbal interactions with the handlers throughout the study suggests the dog acts as a facilitator of social interaction, eliciting positive emotional responses. Dog-assisted therapy shows promising results in the perception of illness timeline and treatment control, indicating potential enhancement of the sense of treatment-related empowerment. However, further study is required.</AbstractText>                <CopyrightInformation>© 2018 Japanese Psychogeriatric Society.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ambrosi</LastName>                    <ForeName>Caterina</ForeName>                    <Initials>C</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1937-9781</Identifier>                    <AffiliationInfo>                        <Affiliation>Psychology Unit, IES Abroad c/o Università Cattolica del Sacro Cuore, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zaiontz</LastName>                    <ForeName>Charles</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Psychology Unit, IES Abroad c/o Università Cattolica del Sacro Cuore, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peragine</LastName>                    <ForeName>Giuseppe</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Fondazione Santa Chiara Long-Term Geriatric Care, Centro Multiservizi per la Popolazione Anziana, Lodi, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sarchi</LastName>                    <ForeName>Simona</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Fondazione Santa Chiara Long-Term Geriatric Care, Centro Multiservizi per la Popolazione Anziana, Lodi, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bona</LastName>                    <ForeName>Francesca</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Fondazione Santa Chiara Long-Term Geriatric Care, Centro Multiservizi per la Popolazione Anziana, Lodi, Italy.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Psychogeriatrics</MedlineTA>            <NlmUniqueID>101230058</NlmUniqueID>            <ISSNLinking>1346-3500</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">animal-assisted therapy</Keyword>            <Keyword MajorTopicYN="N">depression</Keyword>            <Keyword MajorTopicYN="N">dog</Keyword>            <Keyword MajorTopicYN="N">elderly</Keyword>            <Keyword MajorTopicYN="N">illness perception</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>02</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30221438</ArticleId>            <ArticleId IdType="doi">10.1111/psyg.12367</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30221434</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1399-5618</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Bipolar disorders</Title>                <ISOAbbreviation>Bipolar Disord</ISOAbbreviation>            </Journal>            <ArticleTitle>Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12690</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the efficacy and tolerability of lithium for the treatment of acute mania in children and adolescent diagnosed with bipolar disorder.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search up to August 2017 was conducted for clinical trials that included lithium in males and females up to 18 years of age with a diagnosis of bipolar disorder and experiencing a manic or mixed episode according to standardized diagnostic criteria. The protocol was registered in PROSPERO (CRD42017055675).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Four independent studies described in seven manuscripts met the inclusion criteria. Overall, 176 patients were treated with lithium either as a monotherapy or adjunct to risperidone. Efficacy results suggest that lithium may be superior to placebo (standardized mean difference [SMD] -0.42, 95% confidence interval [CI] -0.88 to 0.04), comparable to sodium divalproex (SMD -0.07, 95% CI: -0.31 to 0.18), but significantly less effective than risperidone for treating protracted manic/mixed episodes and comorbid attention-deficit hyperactivity disorder (ADHD) in prepubertal children (SMD 0.85, 95% CI: 0.54 to 1.15). Lithium was not associated with serious adverse events, and was generally well tolerated with common side effects similar to those reported in adults.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Limited data suggests that lithium may be an effective and tolerable treatment for some forms of paediatric mania. However, lithium is clearly inferior in efficacy to risperidone in prepubertal patients diagnosed with protracted manic/mixed episodes and comorbid ADHD. There is a lack of data concerning the efficacy and tolerability of lithium as an acute treatment for classical mania in adolescents and important clinical issues remain unaddressed.</AbstractText>                <CopyrightInformation>© 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Duffy</LastName>                    <ForeName>Anne</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5895-075X</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, Queen's University, Kingston, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Heffer</LastName>                    <ForeName>Naomi</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Goodday</LastName>                    <ForeName>Sarah M</ForeName>                    <Initials>SM</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2159-1754</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weir</LastName>                    <ForeName>Arielle</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Mood Disorders Centre of Ottawa, Ottawa, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Patten</LastName>                    <ForeName>Scott</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Malhi</LastName>                    <ForeName>Gin S</ForeName>                    <Initials>GS</Initials>                    <AffiliationInfo>                        <Affiliation>The University of Sydney School of Medicine, Sydney, Australia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cipriani</LastName>                    <ForeName>Andrea</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5179-8321</Identifier>                    <AffiliationInfo>                        <Affiliation>University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>National Institutes for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>PJT 152976</GrantID>                    <Agency>Canadian Institutes of Health Research</Agency>                    <Country>Canada</Country>                </Grant>                <Grant>                    <Agency>Cuthbertson and Fischer Chair in Pediatric Mental Health, University of Calgary</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Denmark</Country>            <MedlineTA>Bipolar Disord</MedlineTA>            <NlmUniqueID>100883596</NlmUniqueID>            <ISSNLinking>1398-5647</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">adolescents</Keyword>            <Keyword MajorTopicYN="N">bipolar disorder</Keyword>            <Keyword MajorTopicYN="N">children</Keyword>            <Keyword MajorTopicYN="N">efficacy</Keyword>            <Keyword MajorTopicYN="N">lithium</Keyword>            <Keyword MajorTopicYN="N">mania</Keyword>            <Keyword MajorTopicYN="N">manic episode</Keyword>            <Keyword MajorTopicYN="N">meta-analysis</Keyword>            <Keyword MajorTopicYN="N">systematic review</Keyword>            <Keyword MajorTopicYN="N">tolerability</Keyword>            <Keyword MajorTopicYN="N">treatment</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30221434</ArticleId>            <ArticleId IdType="doi">10.1111/bdi.12690</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>